CURE5d
First Patient Dosed With Recombinant Bacillus Calmette-Guérin in Bladder Cancer
Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...
Le Lézard5d
ImmunityBio Announces First Dosing of Recombinant BCG (rBCG) in the U.S. and 60 Sites Are in the Process of Launching
ImmunityBio, Inc. , a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation's largest independent providers of urology and related specialty services, is one of the ...
ImmunityBio announces 1st dosing of rBCG in U.S. and 60 sites pending
ImmunityBio (IBRX) announced U.S. Urology Partners, one of the nation’s largest independent providers of urology and related specialty ...
Merck completes $1B North Carolina expansion — more growth on the way
Merck says the expansion in Durham is part of more than $12 billion the company has invested in U.S. manufacturing and ...